FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1997103395> ?p ?o ?g. }

• W1997103395 endingPage "66" @default.
• W1997103395 startingPage "66" @default.
• W1997103395 abstract "Brief Reports1 July 1981Verapamil-Induced Hyperprolactinemia and GalactorrheaLAWRENCE E. GLUSKIN, M.D., BORIS STRASBERG, M.D., JAYENDRA H. SHAH, M.D.LAWRENCE E. GLUSKIN, M.D.Search for more papers by this author, BORIS STRASBERG, M.D.Search for more papers by this author, JAYENDRA H. SHAH, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-95-1-66 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptVerapamil, a synthetic papaverine derivative, has been reported to have antiarrhythmic, antianginal, and antihypertensive properties in man (1). Although verapamil was introduced in Germany in 1962 and has been in use in much of the world, it has been available for clinical investigation in the United States only recently (1). The oral and intravenous use of verapamil is associated with side effects including gastric intolerance, headache, nervousness, pruritis, hypotension, bradycardia, and asystole (2); however, hyperprolactinemia and galactorrhea have not been reported. We report galactorrhea and hyperprolactinemia that occurred during verapamil therapy in a young woman.A 22-year-old woman had a...References1. SINGH B, ELLRODT G, and PETER C. Verapamil: a review of its pharmacological properties and therapeutic use. Drugs. 1978;15:169-97. CrossrefMedlineGoogle Scholar2. SINGH B, COLLETT J, and CHEW C. New perspectives in the pharmacologic therapy of cardiac arrhythmias. Prog Cardiovasc Dis. 1980;22:243-97. CrossrefMedlineGoogle Scholar3. JACOBS L. Prolactin. In: JAFFE BM, BEHRMAN HR, eds. Methods of Hormone Radioimmunoassay. New York: Academic Press; 1974: 87-102. Google Scholar4. FRIESEN H and HWANG P. Human prolactin. Annu Rev Med. 1973;24:251-70. CrossrefMedlineGoogle Scholar5. NAYLER W and SZETO J. Effect of verapamil on contractility, oxygen utilization and calcium exchangeability in mammalian heart muscle. Cardiovasc Res. 1972;6:120-28. CrossrefMedlineGoogle Scholar6. ETO S, WOOD J, HUTCHINS M, and FLEISCHER N. Pituitary 45C++ uptake and release of ACTH, GH, and TSH: effect of verapamil. Am J Physiol. 1974;226(6):1315-20. CrossrefMedlineGoogle Scholar7. LECLERCQ-MEYER V, MARCHAND J, and MALAISSE W. The role of calcium in glucagon release: studies with verapamil. Diabetes. 1978;27:996-1004. CrossrefMedlineGoogle Scholar8. ISAAC R, MERCERON R, CAILLENS G, RAYMOND J, and ARDAILLOU R. Effect of parathyroid hormone on plasma prolactin in man. J Clin Endocrinol Metab. 1978;47:18-23. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: LAWRENCE E. GLUSKIN, M.D.; BORIS STRASBERG, M.D.; JAYENDRA H. SHAH, M.D.Affiliations: Veterans Administration West Side Medical Center Abraham Lincoln School of Medicine University of Illinois Chicago, Illinois. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byProlactinHyperprolactinemia in Men with Testosterone DeficiencyProlactinomasProlactinomas in Children and AdolescentsProlactin and Its Role in Human ReproductionProlactinomaBreastfeeding and migraine drugsProlactin in Human ReproductionPhysiological and Pathophysiological Alterations of the Neuroendocrine Components of the Reproductive AxisProlactinTranssphenoidal Surgery for ProlactinomasProlactin in Human ReproductionPhysiologic and Pathophysiologic Alterations of the Neuroendocrine Components of the Reproductive AxisDrugs and prolactinMedication-Induced HyperprolactinemiaAntireproductive effect of the calcium channel blocker amlodipine in male ratsProlactinomas y síndromes hiperprolactinémicosMEDICAL TREATMENT OF PROLACTINOMASMechanism of verapamil calcium channel blockade-induced hyperprolactinemiaVerapamil-Induced Hyperprolactememia Complicated by a Pituitary IncidentalomaVerapamil-induced ?primary? polydipsiaNifedipine, but not verapamil, acutely elevates parathyroid hormone levels in premenopausal womenDopaminergic function in rat brain after oral administration of calcium-channel blockers or haloperidol. A microdialysis studyGynaecomastia in association with calcium antagonistsEffect of calcium channel blockers on serum levels of thyroid hormonesDrug‐Induced GynecomastiaEffects of Calcium Channel Blockade withVerapamil on the Prolactin Responsesto TRH, L-Dopa, and BromocriptinePsychopharmacological properties of calcium channel inhibitorsHyperprolactinemia, Galactorrhea, and AtenololShih-Tseng Lee, MDCalcium antagonist flunarizine hydrochloride affects striatal D2 dopamine receptors in the young adult and aged rat brainDrug Information Analysis ServiceDifferent effects of the calcium antagonists nimodipine and flunarizine on dopamine metabolism in the rat brainEFFECT OF NIFEDIPINE ON THYROTROPIN, PROLACTIN, AND THYROID HORMONE RELEASE IN MAN: A PLACEBO-CONTROLLED STUDYDrug-Induced Changes in Prolactin SecretionHormonal and metabolic effects of calcium channel antagonists in manEffect of different Ca2+ entry blockers on dopamine-induced inhibition of in vitro prolactin secretionDiagnostic work-up of hyperprolactinemic disordersProlactinomasVerapamil in treatment of severe schizophreniaProlactinCalcium Antagonistic Properties of Antimanic CompoundsCompetitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cationsCalcium antagonists and endocrine status: lack of effect of oral verapamil on pituitary-testicular and pituitary-thyroid function.Introduction Psychoneuropharmacology and Neuroendocrinology Implications in Neuropsychiatric ResearchGalactorrhea in the adolescentThe effect of enalapril on serum prolactin.Hyperprolactinemia-galactorrhea induced by verapamilClinical use of antiarrhythmic drugsClinical applications of slow channel blocking compoundsCalcium antagonists: A new class of drugsThe influence of nisoldipine — A “calcium entry blocker” on drug induced sterotyped behavior in ratsHyperprolactinemic disorders 1 July 1981Volume 95, Issue 1Page: 66-67KeywordsAnxietyBradycardiaEndocrinologyHeadachesHeartHypotensionInterleukinsPruritus ePublished: 1 December 2008 Issue Published: 1 July 1981 PDF downloadLoading ..." @default.
• W1997103395 created "2016-06-24" @default.
• W1997103395 creator A5022355842 @default.
• W1997103395 creator A5052451181 @default.
• W1997103395 creator A5087919602 @default.
• W1997103395 date "1981-07-01" @default.
• W1997103395 modified "2023-09-26" @default.
• W1997103395 title "Verapamil-Induced Hyperprolactinemia and Galactorrhea" @default.
• W1997103395 cites W2026275409 @default.
• W1997103395 cites W2057443384 @default.
• W1997103395 cites W2100129086 @default.
• W1997103395 cites W2138710066 @default.
• W1997103395 cites W2147101763 @default.
• W1997103395 cites W27132396 @default.
• W1997103395 doi "https://doi.org/10.7326/0003-4819-95-1-66" @default.
• W1997103395 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7195677" @default.
• W1997103395 hasPublicationYear "1981" @default.
• W1997103395 type Work @default.
• W1997103395 sameAs 1997103395 @default.
• W1997103395 citedByCount "60" @default.
• W1997103395 countsByYear W19971033952014 @default.
• W1997103395 countsByYear W19971033952017 @default.
• W1997103395 countsByYear W19971033952019 @default.
• W1997103395 countsByYear W19971033952020 @default.
• W1997103395 countsByYear W19971033952021 @default.
• W1997103395 crossrefType "journal-article" @default.
• W1997103395 hasAuthorship W1997103395A5022355842 @default.
• W1997103395 hasAuthorship W1997103395A5052451181 @default.
• W1997103395 hasAuthorship W1997103395A5087919602 @default.
• W1997103395 hasConcept C126322002 @default.
• W1997103395 hasConcept C2776952824 @default.
• W1997103395 hasConcept C2777022698 @default.
• W1997103395 hasConcept C2777495988 @default.
• W1997103395 hasConcept C2777863693 @default.
• W1997103395 hasConcept C2777953023 @default.
• W1997103395 hasConcept C2779064019 @default.
• W1997103395 hasConcept C519063684 @default.
• W1997103395 hasConcept C71315377 @default.
• W1997103395 hasConcept C71924100 @default.
• W1997103395 hasConcept C84393581 @default.
• W1997103395 hasConceptScore W1997103395C126322002 @default.
• W1997103395 hasConceptScore W1997103395C2776952824 @default.
• W1997103395 hasConceptScore W1997103395C2777022698 @default.
• W1997103395 hasConceptScore W1997103395C2777495988 @default.
• W1997103395 hasConceptScore W1997103395C2777863693 @default.
• W1997103395 hasConceptScore W1997103395C2777953023 @default.
• W1997103395 hasConceptScore W1997103395C2779064019 @default.
• W1997103395 hasConceptScore W1997103395C519063684 @default.
• W1997103395 hasConceptScore W1997103395C71315377 @default.
• W1997103395 hasConceptScore W1997103395C71924100 @default.
• W1997103395 hasConceptScore W1997103395C84393581 @default.
• W1997103395 hasIssue "1" @default.
• W1997103395 hasLocation W19971033951 @default.
• W1997103395 hasLocation W19971033952 @default.
• W1997103395 hasOpenAccess W1997103395 @default.
• W1997103395 hasPrimaryLocation W19971033951 @default.
• W1997103395 hasRelatedWork W1991604522 @default.
• W1997103395 hasRelatedWork W1997103395 @default.
• W1997103395 hasRelatedWork W2032304178 @default.
• W1997103395 hasRelatedWork W2045573997 @default.
• W1997103395 hasRelatedWork W2108003509 @default.
• W1997103395 hasRelatedWork W2166804973 @default.
• W1997103395 hasRelatedWork W2399612755 @default.
• W1997103395 hasRelatedWork W2414106935 @default.
• W1997103395 hasRelatedWork W183484172 @default.
• W1997103395 hasRelatedWork W2188492038 @default.
• W1997103395 hasVolume "95" @default.
• W1997103395 isParatext "false" @default.
• W1997103395 isRetracted "false" @default.
• W1997103395 magId "1997103395" @default.
• W1997103395 workType "article" @default.